NCT06608433View on ClinicalTrials.gov

Glucagon-like Peptide-1 Receptor Agnoists for the Assessment of Adrenal Function

NARecruitingINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

January 16, 2025

Primary Completion Date

July 31, 2025

Study Completion Date

August 31, 2025

Conditions
Healthy Volunteer StudyHPACortisol DeficiencyAdrenal Insufficiency
Interventions
DRUG

semaglutide

semaglutide/Rybelsus will be administered as a single oral dose

DRUG

Placebo

Placebo pills will be administered as a single oral dose

Trial Locations (1)

Unknown

RECRUITING

University Hospital Basel, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER